This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
100mg | $750 | Check With Us |
250mg | $1250 | Check With Us |
500mg | $1875 | Check With Us |
Cat #: V41443 CAS #: 2222112-77-6 Purity ≥ 99%
Description: Bavdegalutamide (ARV110; ARV-110) is an orally bioavailable PROTAC-based Androgen Receptor (AR) degrader with potential anticancer activity.
References: Taavi K Neklesa,et al. ARV-110: an oral androgen receptor PROTAC degrader for prostate cancer. GU ASCO 2019
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 812.3004 |
---|---|
Molecular Formula | C41H43ClFN9O6 |
CAS No. | 2222112-77-6 |
Protocol | In Vitro | Bavdegalutamide (10-1000 nM) suppresses the expression of the AR-target gene PSA, inhibits AR-dependent cell proliferation, and induces apoptosis at low nanomolar concentrations. |
---|---|---|
In Vivo | Bavdegalutamide (oral gavage; 1 mg/kg; QD) exhibits a greater than 90% AR degradation in vivo. In LNCaP, VCaP and prostate cancer patient derived xenograft (PDX) models, Bavdegalutamide also exhibits significant inhibition of tumor growth and AR signaling. |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 1.2311 mL | 6.1554 mL | 12.3107 mL | 24.6214 mL |
5mM | 0.2462 mL | 1.2311 mL | 2.4621 mL | 4.9243 mL |
10mM | 0.1231 mL | 0.6155 mL | 1.2311 mL | 2.4621 mL |
20mM | 0.0616 mL | 0.3078 mL | 0.6155 mL | 1.2311 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.